Elizabeth Kovacs
Concepts (549)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 60 | 2025 | 286 | 17.840 |
Why?
| Ethanol | 54 | 2025 | 577 | 9.020 |
Why?
| Alcoholic Intoxication | 15 | 2023 | 63 | 5.840 |
Why?
| Alcohol Drinking | 23 | 2024 | 742 | 4.380 |
Why?
| Pneumonia | 13 | 2025 | 612 | 4.270 |
Why?
| Aging | 25 | 2025 | 1767 | 3.630 |
Why?
| Inflammation | 30 | 2024 | 2694 | 3.410 |
Why?
| Alcoholism | 22 | 2024 | 759 | 3.260 |
Why?
| Gastrointestinal Microbiome | 9 | 2025 | 635 | 3.130 |
Why?
| Lung Transplantation | 15 | 2019 | 276 | 2.810 |
Why?
| Immunity, Innate | 12 | 2017 | 802 | 2.610 |
Why?
| Interleukin-6 | 16 | 2023 | 715 | 2.450 |
Why?
| Feces | 4 | 2025 | 430 | 2.230 |
Why?
| Neutrophils | 16 | 2022 | 1203 | 2.150 |
Why?
| Macrophages, Alveolar | 9 | 2022 | 389 | 2.150 |
Why?
| Lung | 24 | 2024 | 3925 | 2.120 |
Why?
| Liver Diseases | 5 | 2021 | 284 | 2.050 |
Why?
| Dysbiosis | 5 | 2025 | 166 | 2.030 |
Why?
| Mice | 66 | 2025 | 16543 | 1.990 |
Why?
| Burns, Inhalation | 5 | 2020 | 9 | 1.980 |
Why?
| Intestines | 4 | 2022 | 346 | 1.960 |
Why?
| Binge Drinking | 8 | 2023 | 34 | 1.940 |
Why?
| Animals | 94 | 2025 | 34628 | 1.880 |
Why?
| Wound Healing | 11 | 2015 | 308 | 1.870 |
Why?
| Cytokines | 19 | 2025 | 1995 | 1.820 |
Why?
| Macrophages | 13 | 2016 | 1452 | 1.800 |
Why?
| Mice, Inbred C57BL | 35 | 2025 | 5270 | 1.790 |
Why?
| Gastroesophageal Reflux | 10 | 2014 | 240 | 1.740 |
Why?
| Bronchoalveolar Lavage Fluid | 15 | 2018 | 642 | 1.680 |
Why?
| Age Factors | 17 | 2025 | 3133 | 1.590 |
Why?
| Lung Diseases | 9 | 2018 | 755 | 1.580 |
Why?
| Glycerophospholipids | 5 | 2024 | 32 | 1.510 |
Why?
| Phagocytosis | 7 | 2016 | 361 | 1.420 |
Why?
| Smoke Inhalation Injury | 6 | 2013 | 24 | 1.380 |
Why?
| Neutrophil Infiltration | 8 | 2016 | 102 | 1.340 |
Why?
| Respiratory Aspiration | 4 | 2013 | 32 | 1.250 |
Why?
| Bacterial Translocation | 6 | 2016 | 38 | 1.250 |
Why?
| Public Opinion | 4 | 2023 | 65 | 1.220 |
Why?
| Disease Models, Animal | 21 | 2025 | 3994 | 1.210 |
Why?
| Pseudomonas Infections | 4 | 2016 | 217 | 1.170 |
Why?
| Macrophage Activation | 6 | 2019 | 178 | 1.140 |
Why?
| Central Nervous System Depressants | 3 | 2015 | 82 | 1.130 |
Why?
| Immune System | 5 | 2017 | 175 | 1.040 |
Why?
| Bronchiolitis Obliterans | 6 | 2014 | 71 | 1.020 |
Why?
| Liver | 10 | 2025 | 1832 | 0.970 |
Why?
| Radiation Injuries, Experimental | 3 | 2013 | 22 | 0.970 |
Why?
| Male | 77 | 2025 | 63146 | 0.950 |
Why?
| Wound Infection | 2 | 2016 | 32 | 0.950 |
Why?
| Pneumonia, Bacterial | 2 | 2016 | 112 | 0.900 |
Why?
| Postoperative Complications | 6 | 2018 | 2494 | 0.850 |
Why?
| Mice, Inbred BALB C | 12 | 2020 | 1230 | 0.840 |
Why?
| Skin | 6 | 2016 | 737 | 0.840 |
Why?
| Humans | 98 | 2025 | 128896 | 0.820 |
Why?
| Radiation Injuries | 2 | 2016 | 139 | 0.800 |
Why?
| Chemokines | 8 | 2023 | 227 | 0.800 |
Why?
| Biomarkers | 19 | 2024 | 3874 | 0.790 |
Why?
| Biomedical Research | 4 | 2018 | 654 | 0.780 |
Why?
| Pneumonia, Pneumococcal | 1 | 2022 | 41 | 0.770 |
Why?
| Delirium | 1 | 2023 | 77 | 0.760 |
Why?
| Signal Transduction | 14 | 2022 | 4857 | 0.750 |
Why?
| Wounds and Injuries | 4 | 2015 | 718 | 0.740 |
Why?
| Tight Junctions | 1 | 2021 | 74 | 0.740 |
Why?
| Pneumococcal Infections | 1 | 2022 | 110 | 0.720 |
Why?
| Immunity, Cellular | 5 | 2018 | 266 | 0.720 |
Why?
| Astrocytes | 1 | 2022 | 184 | 0.710 |
Why?
| Female | 60 | 2025 | 68162 | 0.690 |
Why?
| Leukocytes | 3 | 2011 | 301 | 0.680 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.680 |
Why?
| Estrogens | 2 | 2016 | 348 | 0.670 |
Why?
| von Willebrand Factor | 1 | 2019 | 59 | 0.660 |
Why?
| Intestinal Mucosa | 3 | 2021 | 569 | 0.650 |
Why?
| Gastrointestinal Tract | 2 | 2020 | 182 | 0.630 |
Why?
| Allergy and Immunology | 2 | 2017 | 60 | 0.630 |
Why?
| Fatty Liver | 3 | 2017 | 230 | 0.620 |
Why?
| Hepatitis, Alcoholic | 1 | 2018 | 13 | 0.610 |
Why?
| Epigenesis, Genetic | 4 | 2022 | 613 | 0.610 |
Why?
| Immunosenescence | 2 | 2017 | 4 | 0.610 |
Why?
| Pseudomonas aeruginosa | 5 | 2014 | 343 | 0.610 |
Why?
| Pepsin A | 3 | 2014 | 19 | 0.600 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 50 | 0.600 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2022 | 1204 | 0.600 |
Why?
| Flow Cytometry | 6 | 2018 | 1146 | 0.600 |
Why?
| Chemokine CCL2 | 1 | 2017 | 122 | 0.560 |
Why?
| Aged | 24 | 2024 | 22035 | 0.550 |
Why?
| Sepsis | 5 | 2023 | 561 | 0.550 |
Why?
| Histone Deacetylase 1 | 1 | 2016 | 22 | 0.540 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2023 | 544 | 0.540 |
Why?
| Tissue Donors | 3 | 2018 | 398 | 0.530 |
Why?
| Kupffer Cells | 1 | 2016 | 49 | 0.530 |
Why?
| Length of Stay | 3 | 2019 | 1126 | 0.530 |
Why?
| Spleen | 5 | 2011 | 518 | 0.520 |
Why?
| Myosin-Light-Chain Kinase | 2 | 2014 | 20 | 0.520 |
Why?
| Middle Aged | 30 | 2024 | 30977 | 0.520 |
Why?
| Pulmonary Edema | 1 | 2016 | 105 | 0.520 |
Why?
| Inflammation Mediators | 6 | 2015 | 503 | 0.510 |
Why?
| Laparoscopy | 5 | 2014 | 452 | 0.500 |
Why?
| Granulocyte Colony-Stimulating Factor | 2 | 2013 | 72 | 0.500 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 267 | 0.500 |
Why?
| Adaptive Immunity | 2 | 2016 | 161 | 0.500 |
Why?
| Intestine, Small | 2 | 2016 | 140 | 0.490 |
Why?
| Microbiota | 1 | 2023 | 724 | 0.490 |
Why?
| Bradykinin B2 Receptor Antagonists | 1 | 2015 | 1 | 0.480 |
Why?
| Oxidative Stress | 6 | 2025 | 1220 | 0.480 |
Why?
| Immunologic Memory | 1 | 2017 | 335 | 0.480 |
Why?
| Bradykinin | 1 | 2015 | 46 | 0.470 |
Why?
| Extracellular Traps | 1 | 2015 | 45 | 0.470 |
Why?
| Models, Animal | 6 | 2019 | 370 | 0.470 |
Why?
| Dehydration | 1 | 2015 | 48 | 0.470 |
Why?
| Respiration | 1 | 2015 | 191 | 0.460 |
Why?
| Primary Graft Dysfunction | 1 | 2014 | 30 | 0.460 |
Why?
| Histones | 2 | 2016 | 584 | 0.450 |
Why?
| Esophageal pH Monitoring | 1 | 2014 | 23 | 0.450 |
Why?
| Lipopolysaccharides | 5 | 2012 | 877 | 0.440 |
Why?
| Breath Tests | 3 | 2016 | 91 | 0.440 |
Why?
| Monocytes | 1 | 2016 | 553 | 0.420 |
Why?
| Congresses as Topic | 4 | 2020 | 217 | 0.420 |
Why?
| Scleroderma, Systemic | 1 | 2014 | 109 | 0.420 |
Why?
| Dendritic Cells | 3 | 2016 | 478 | 0.410 |
Why?
| Research Personnel | 1 | 2014 | 161 | 0.410 |
Why?
| Ileitis | 1 | 2013 | 32 | 0.410 |
Why?
| Adult | 31 | 2024 | 35361 | 0.410 |
Why?
| Mentors | 1 | 2014 | 174 | 0.410 |
Why?
| Permeability | 3 | 2022 | 158 | 0.410 |
Why?
| Solvents | 1 | 2013 | 107 | 0.410 |
Why?
| Chemotaxis, Leukocyte | 1 | 2013 | 137 | 0.400 |
Why?
| Career Choice | 1 | 2014 | 211 | 0.400 |
Why?
| Graft Rejection | 2 | 2013 | 566 | 0.400 |
Why?
| Intestinal Diseases | 1 | 2012 | 35 | 0.390 |
Why?
| Leukocyte Count | 5 | 2013 | 328 | 0.390 |
Why?
| rac GTP-Binding Proteins | 1 | 2012 | 32 | 0.390 |
Why?
| Injury Severity Score | 5 | 2017 | 513 | 0.390 |
Why?
| Phagosomes | 1 | 2012 | 43 | 0.390 |
Why?
| Fundoplication | 1 | 2012 | 54 | 0.390 |
Why?
| Receptors, IgG | 1 | 2012 | 73 | 0.380 |
Why?
| Staphylococcal Infections | 2 | 2013 | 385 | 0.380 |
Why?
| Antibodies | 2 | 2013 | 392 | 0.380 |
Why?
| Ischemia | 1 | 2015 | 396 | 0.370 |
Why?
| Alanine Transaminase | 4 | 2021 | 147 | 0.370 |
Why?
| Prospective Studies | 9 | 2021 | 7060 | 0.370 |
Why?
| Immunologic Factors | 2 | 2016 | 227 | 0.370 |
Why?
| Ligands | 2 | 2023 | 614 | 0.360 |
Why?
| Logistic Models | 6 | 2019 | 1963 | 0.360 |
Why?
| Toll-Like Receptor 4 | 2 | 2010 | 294 | 0.360 |
Why?
| Immunity | 2 | 2010 | 132 | 0.360 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 822 | 0.360 |
Why?
| Mice, Knockout | 7 | 2013 | 2770 | 0.360 |
Why?
| Down-Regulation | 1 | 2013 | 637 | 0.340 |
Why?
| Cause of Death | 3 | 2019 | 392 | 0.340 |
Why?
| Cell Separation | 1 | 2011 | 311 | 0.340 |
Why?
| Respiratory Function Tests | 3 | 2025 | 596 | 0.330 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 151 | 0.330 |
Why?
| Actins | 1 | 2012 | 403 | 0.330 |
Why?
| Toll-Like Receptor 2 | 1 | 2010 | 124 | 0.330 |
Why?
| Environmental Pollutants | 1 | 2011 | 142 | 0.330 |
Why?
| Immune Tolerance | 1 | 2012 | 348 | 0.320 |
Why?
| Ileum | 2 | 2024 | 113 | 0.320 |
Why?
| Receptors, Interleukin-8B | 2 | 2010 | 24 | 0.320 |
Why?
| Interleukin-12 | 2 | 2013 | 118 | 0.320 |
Why?
| Illinois | 4 | 2017 | 39 | 0.300 |
Why?
| Occludin | 2 | 2021 | 11 | 0.300 |
Why?
| Time Factors | 9 | 2019 | 6568 | 0.300 |
Why?
| Chemokine CXCL1 | 2 | 2020 | 75 | 0.290 |
Why?
| Aspartate Aminotransferases | 2 | 2021 | 86 | 0.290 |
Why?
| Respiration, Artificial | 1 | 2012 | 594 | 0.290 |
Why?
| Risk Factors | 11 | 2024 | 9792 | 0.290 |
Why?
| Smoking | 2 | 2013 | 1501 | 0.280 |
Why?
| Apoptosis | 6 | 2025 | 2481 | 0.280 |
Why?
| Gastroenteritis | 1 | 2008 | 66 | 0.280 |
Why?
| Bronchoscopy | 3 | 2013 | 215 | 0.280 |
Why?
| Plethysmography | 2 | 2019 | 109 | 0.280 |
Why?
| Peptides | 1 | 2012 | 902 | 0.270 |
Why?
| Peroxidase | 3 | 2016 | 183 | 0.270 |
Why?
| Trachea | 1 | 2008 | 228 | 0.260 |
Why?
| Statistics, Nonparametric | 5 | 2013 | 424 | 0.260 |
Why?
| Bacteria | 3 | 2023 | 812 | 0.240 |
Why?
| Skin Ulcer | 2 | 2015 | 13 | 0.240 |
Why?
| Retrospective Studies | 10 | 2023 | 14546 | 0.240 |
Why?
| Bacteroidetes | 1 | 2024 | 23 | 0.240 |
Why?
| Fecal Microbiota Transplantation | 1 | 2024 | 18 | 0.230 |
Why?
| Mitochondria, Liver | 1 | 2025 | 73 | 0.230 |
Why?
| Aged, 80 and over | 5 | 2017 | 7050 | 0.230 |
Why?
| Survival Analysis | 3 | 2019 | 1282 | 0.230 |
Why?
| ROC Curve | 5 | 2018 | 500 | 0.230 |
Why?
| Exhalation | 2 | 2016 | 38 | 0.220 |
Why?
| Burn Units | 2 | 2022 | 42 | 0.220 |
Why?
| Hospital Mortality | 2 | 2019 | 853 | 0.220 |
Why?
| Toxoplasmosis | 1 | 2024 | 37 | 0.220 |
Why?
| Toxoplasma | 1 | 2024 | 39 | 0.220 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 154 | 0.220 |
Why?
| Fatty Acids, Volatile | 1 | 2024 | 57 | 0.220 |
Why?
| Cohort Studies | 9 | 2019 | 5394 | 0.220 |
Why?
| Homeostasis | 2 | 2020 | 604 | 0.220 |
Why?
| Hepatocytes | 1 | 2025 | 215 | 0.220 |
Why?
| Multivariate Analysis | 3 | 2023 | 1504 | 0.210 |
Why?
| Hawaii | 1 | 2023 | 40 | 0.210 |
Why?
| Zonula Occludens-1 Protein | 2 | 2013 | 15 | 0.210 |
Why?
| alpha-Defensins | 1 | 2022 | 11 | 0.200 |
Why?
| Whole-Body Irradiation | 2 | 2013 | 76 | 0.200 |
Why?
| Mitochondrial Proteins | 1 | 2025 | 234 | 0.200 |
Why?
| Phenotype | 4 | 2020 | 3059 | 0.200 |
Why?
| Body Surface Area | 1 | 2022 | 34 | 0.200 |
Why?
| Sex Characteristics | 3 | 2016 | 722 | 0.200 |
Why?
| Young Adult | 8 | 2024 | 12286 | 0.200 |
Why?
| Veterans | 2 | 2024 | 1397 | 0.200 |
Why?
| Veterans Health | 1 | 2024 | 172 | 0.200 |
Why?
| Critical Illness | 2 | 2018 | 753 | 0.200 |
Why?
| Neurodegenerative Diseases | 1 | 2023 | 107 | 0.190 |
Why?
| Caspases | 1 | 2023 | 248 | 0.190 |
Why?
| Fluorescent Antibody Technique | 3 | 2014 | 392 | 0.190 |
Why?
| Interleukin-1beta | 3 | 2020 | 376 | 0.190 |
Why?
| Hippocampus | 2 | 2025 | 785 | 0.190 |
Why?
| Colon | 1 | 2023 | 246 | 0.180 |
Why?
| Malondialdehyde | 1 | 2021 | 28 | 0.180 |
Why?
| Injections, Intraperitoneal | 2 | 2013 | 106 | 0.180 |
Why?
| Frailty | 1 | 2024 | 148 | 0.180 |
Why?
| Interleukins | 2 | 2014 | 245 | 0.180 |
Why?
| Phosphorylation | 3 | 2016 | 1685 | 0.180 |
Why?
| Nanoparticles | 1 | 2025 | 358 | 0.180 |
Why?
| NF-kappa B | 1 | 2025 | 685 | 0.180 |
Why?
| Lipid Peroxidation | 1 | 2021 | 147 | 0.180 |
Why?
| Analysis of Variance | 3 | 2014 | 1283 | 0.180 |
Why?
| Ventricular Dysfunction, Right | 1 | 2023 | 226 | 0.180 |
Why?
| Streptococcus pneumoniae | 1 | 2022 | 157 | 0.170 |
Why?
| Caspase 3 | 3 | 2023 | 241 | 0.170 |
Why?
| Boston | 1 | 2020 | 89 | 0.170 |
Why?
| Resistin | 1 | 2019 | 10 | 0.170 |
Why?
| Organ Specificity | 1 | 2020 | 296 | 0.170 |
Why?
| Gastric Inhibitory Polypeptide | 1 | 2019 | 22 | 0.170 |
Why?
| Air Pollutants | 1 | 2024 | 321 | 0.170 |
Why?
| Ghrelin | 1 | 2019 | 33 | 0.170 |
Why?
| Metformin | 1 | 2023 | 307 | 0.160 |
Why?
| Mannose-Binding Lectins | 1 | 2019 | 12 | 0.160 |
Why?
| Cells, Cultured | 7 | 2016 | 4048 | 0.160 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 86 | 0.160 |
Why?
| Natural Killer T-Cells | 2 | 2010 | 64 | 0.160 |
Why?
| Predictive Value of Tests | 3 | 2019 | 1967 | 0.160 |
Why?
| Glutathione | 1 | 2021 | 333 | 0.160 |
Why?
| Lectins, C-Type | 1 | 2019 | 69 | 0.160 |
Why?
| Risk Assessment | 5 | 2019 | 3286 | 0.160 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2010 | 145 | 0.160 |
Why?
| Life Style | 2 | 2014 | 459 | 0.160 |
Why?
| Cognitive Dysfunction | 1 | 2023 | 328 | 0.160 |
Why?
| Fires | 1 | 2020 | 88 | 0.160 |
Why?
| Cell Count | 2 | 2016 | 316 | 0.160 |
Why?
| Multiple Organ Failure | 2 | 2017 | 122 | 0.160 |
Why?
| Administration, Oral | 2 | 2013 | 783 | 0.150 |
Why?
| In Situ Nick-End Labeling | 1 | 2018 | 125 | 0.150 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2019 | 111 | 0.150 |
Why?
| Leptin | 1 | 2019 | 217 | 0.150 |
Why?
| Prognosis | 3 | 2018 | 3787 | 0.150 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2018 | 77 | 0.150 |
Why?
| Toll-Like Receptors | 2 | 2009 | 182 | 0.140 |
Why?
| Intensive Care Units | 4 | 2019 | 730 | 0.140 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 957 | 0.140 |
Why?
| Mental Health | 1 | 2024 | 675 | 0.140 |
Why?
| RNA, Ribosomal, 16S | 1 | 2020 | 520 | 0.140 |
Why?
| Reproducibility of Results | 2 | 2019 | 3042 | 0.140 |
Why?
| Transcriptome | 1 | 2023 | 871 | 0.140 |
Why?
| Tobacco Use | 1 | 2017 | 59 | 0.140 |
Why?
| Needs Assessment | 1 | 2019 | 360 | 0.140 |
Why?
| Receptors, Cell Surface | 1 | 2019 | 379 | 0.140 |
Why?
| United States | 10 | 2024 | 13975 | 0.130 |
Why?
| Follow-Up Studies | 2 | 2018 | 4917 | 0.130 |
Why?
| Incidence | 3 | 2019 | 2634 | 0.130 |
Why?
| Phylogeny | 1 | 2020 | 843 | 0.130 |
Why?
| Ovariectomy | 1 | 2016 | 135 | 0.130 |
Why?
| Monocyte Chemoattractant Proteins | 1 | 2015 | 8 | 0.130 |
Why?
| Chemokine CXCL2 | 1 | 2015 | 45 | 0.130 |
Why?
| Acetylation | 1 | 2016 | 235 | 0.130 |
Why?
| Dose-Response Relationship, Drug | 3 | 2010 | 1968 | 0.130 |
Why?
| Polymerase Chain Reaction | 1 | 2018 | 1045 | 0.120 |
Why?
| Apicomplexa | 1 | 2015 | 2 | 0.120 |
Why?
| Regression Analysis | 3 | 2013 | 987 | 0.120 |
Why?
| Imidazoles | 1 | 2016 | 224 | 0.120 |
Why?
| Cognition | 1 | 2023 | 1093 | 0.120 |
Why?
| Linear Models | 1 | 2017 | 817 | 0.120 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2015 | 21 | 0.120 |
Why?
| Enzyme Inhibitors | 2 | 2016 | 827 | 0.120 |
Why?
| Killer Cells, Natural | 2 | 2008 | 422 | 0.120 |
Why?
| Hematocrit | 1 | 2015 | 93 | 0.120 |
Why?
| Wasting Syndrome | 1 | 2014 | 11 | 0.120 |
Why?
| Radiation Dosage | 1 | 2016 | 159 | 0.120 |
Why?
| Insulin | 2 | 2019 | 2311 | 0.120 |
Why?
| Electric Stimulation Therapy | 1 | 2015 | 58 | 0.110 |
Why?
| Alcohol-Related Disorders | 1 | 2015 | 114 | 0.110 |
Why?
| Respiratory Tract Diseases | 1 | 2016 | 151 | 0.110 |
Why?
| Systemic Inflammatory Response Syndrome | 2 | 2014 | 84 | 0.110 |
Why?
| Gene Expression | 2 | 2018 | 1476 | 0.110 |
Why?
| Leukocyte Disorders | 1 | 2014 | 10 | 0.110 |
Why?
| Chi-Square Distribution | 2 | 2013 | 513 | 0.110 |
Why?
| Interleukin-23 | 1 | 2014 | 19 | 0.110 |
Why?
| Viruses | 1 | 2015 | 99 | 0.110 |
Why?
| Sex Factors | 4 | 2019 | 1947 | 0.110 |
Why?
| Immune System Diseases | 1 | 2014 | 33 | 0.110 |
Why?
| Caspase 8 | 1 | 2013 | 48 | 0.110 |
Why?
| Fungi | 1 | 2015 | 138 | 0.110 |
Why?
| Lung Injury | 1 | 2016 | 214 | 0.110 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 52 | 0.110 |
Why?
| Faculty | 1 | 2014 | 132 | 0.110 |
Why?
| Lymphocyte Subsets | 1 | 2013 | 85 | 0.110 |
Why?
| Th17 Cells | 1 | 2014 | 81 | 0.110 |
Why?
| Myosin Light Chains | 1 | 2013 | 27 | 0.110 |
Why?
| Adipose Tissue | 2 | 2015 | 588 | 0.100 |
Why?
| Employment | 1 | 2014 | 161 | 0.100 |
Why?
| Pyridines | 1 | 2016 | 472 | 0.100 |
Why?
| Immunoassay | 1 | 2013 | 101 | 0.100 |
Why?
| Creatinine | 1 | 2015 | 485 | 0.100 |
Why?
| Calcitonin | 1 | 2012 | 24 | 0.100 |
Why?
| Bile Acids and Salts | 1 | 2014 | 194 | 0.100 |
Why?
| Bacterial Load | 1 | 2012 | 67 | 0.100 |
Why?
| Vinculin | 1 | 2012 | 10 | 0.100 |
Why?
| Syndrome | 1 | 2013 | 342 | 0.100 |
Why?
| Anti-Infective Agents | 1 | 2015 | 246 | 0.100 |
Why?
| Paxillin | 1 | 2012 | 10 | 0.100 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 252 | 0.100 |
Why?
| Receptors, Interleukin-4 | 1 | 2011 | 15 | 0.100 |
Why?
| Pregnancy | 2 | 2023 | 6247 | 0.100 |
Why?
| Cell Differentiation | 2 | 2016 | 1854 | 0.100 |
Why?
| Decidua | 1 | 1992 | 23 | 0.100 |
Why?
| Chorionic Villi | 1 | 1992 | 22 | 0.100 |
Why?
| Receptors, Interleukin-2 | 1 | 1992 | 65 | 0.100 |
Why?
| Focal Adhesions | 1 | 2012 | 42 | 0.100 |
Why?
| Ubiquitin | 1 | 2012 | 62 | 0.100 |
Why?
| Protein Precursors | 1 | 2012 | 126 | 0.090 |
Why?
| Hypertension, Pulmonary | 1 | 2023 | 1876 | 0.090 |
Why?
| Chemokine CXCL12 | 1 | 2012 | 79 | 0.090 |
Why?
| rho GTP-Binding Proteins | 1 | 2012 | 63 | 0.090 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2011 | 172 | 0.090 |
Why?
| Blood Glucose | 2 | 2019 | 2086 | 0.090 |
Why?
| Polymerization | 1 | 2012 | 124 | 0.090 |
Why?
| Vehicle Emissions | 1 | 2011 | 55 | 0.090 |
Why?
| Confidence Intervals | 1 | 2012 | 318 | 0.090 |
Why?
| Research Support as Topic | 1 | 2012 | 113 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 289 | 0.090 |
Why?
| Phagocytes | 2 | 2009 | 95 | 0.090 |
Why?
| Pulmonary Alveoli | 1 | 2013 | 403 | 0.090 |
Why?
| Tissue Engineering | 1 | 2015 | 389 | 0.090 |
Why?
| Specimen Handling | 1 | 2012 | 163 | 0.090 |
Why?
| Cytoskeleton | 1 | 2012 | 177 | 0.090 |
Why?
| Bone Marrow Cells | 1 | 2011 | 291 | 0.090 |
Why?
| Nitric Oxide | 1 | 2016 | 892 | 0.090 |
Why?
| Edema | 1 | 2011 | 127 | 0.090 |
Why?
| Immunohistochemistry | 1 | 2015 | 1694 | 0.090 |
Why?
| Writing | 1 | 2012 | 92 | 0.090 |
Why?
| Body Composition | 1 | 2014 | 654 | 0.090 |
Why?
| Ozone | 1 | 2011 | 110 | 0.090 |
Why?
| Dermatitis | 1 | 2010 | 21 | 0.090 |
Why?
| Bacteremia | 1 | 2012 | 190 | 0.090 |
Why?
| Equipment Design | 1 | 2012 | 522 | 0.080 |
Why?
| Heart Failure | 1 | 2023 | 2142 | 0.080 |
Why?
| Trophoblasts | 1 | 1992 | 186 | 0.080 |
Why?
| Mass Screening | 2 | 2015 | 1121 | 0.080 |
Why?
| Adolescent | 5 | 2017 | 20197 | 0.080 |
Why?
| DNA | 2 | 2015 | 1406 | 0.080 |
Why?
| Adiposity | 1 | 2014 | 505 | 0.080 |
Why?
| Cystic Fibrosis | 1 | 2019 | 1061 | 0.080 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2011 | 215 | 0.080 |
Why?
| Respiration Disorders | 1 | 2010 | 73 | 0.080 |
Why?
| Interleukin-18 | 1 | 2010 | 239 | 0.080 |
Why?
| Odds Ratio | 1 | 2012 | 1019 | 0.080 |
Why?
| Severity of Illness Index | 2 | 2019 | 2767 | 0.080 |
Why?
| Histiocytes | 1 | 2008 | 7 | 0.080 |
Why?
| Acute Lung Injury | 1 | 2012 | 278 | 0.080 |
Why?
| Escherichia coli K12 | 1 | 2008 | 8 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 861 | 0.080 |
Why?
| Membrane Fluidity | 1 | 2008 | 11 | 0.080 |
Why?
| Hypersensitivity, Delayed | 1 | 2008 | 28 | 0.080 |
Why?
| Protein Kinase Inhibitors | 1 | 2014 | 870 | 0.080 |
Why?
| Membrane Microdomains | 1 | 2008 | 32 | 0.070 |
Why?
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 14 | 0.070 |
Why?
| Interleukin-2 | 1 | 2009 | 427 | 0.070 |
Why?
| Shock | 1 | 2009 | 96 | 0.070 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 86 | 0.070 |
Why?
| Comorbidity | 3 | 2019 | 1542 | 0.070 |
Why?
| Manometry | 3 | 2013 | 92 | 0.070 |
Why?
| Opportunistic Infections | 1 | 2008 | 46 | 0.070 |
Why?
| Cell Survival | 2 | 2025 | 1082 | 0.070 |
Why?
| Capillary Permeability | 1 | 2008 | 141 | 0.070 |
Why?
| Testis | 1 | 2008 | 143 | 0.070 |
Why?
| Intubation, Gastrointestinal | 1 | 2008 | 76 | 0.070 |
Why?
| Staphylococcus aureus | 1 | 2011 | 429 | 0.070 |
Why?
| Pediatric Obesity | 1 | 2014 | 568 | 0.070 |
Why?
| Protein Kinases | 1 | 2009 | 305 | 0.070 |
Why?
| Survival Rate | 1 | 2012 | 1884 | 0.070 |
Why?
| Mast Cells | 1 | 2008 | 142 | 0.070 |
Why?
| Neovascularization, Physiologic | 1 | 2008 | 179 | 0.070 |
Why?
| Diet | 1 | 2014 | 1205 | 0.070 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2008 | 176 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 3 | 2013 | 542 | 0.070 |
Why?
| Gonadal Steroid Hormones | 1 | 2008 | 134 | 0.070 |
Why?
| Angiogenesis Inhibitors | 1 | 2008 | 221 | 0.070 |
Why?
| In Vitro Techniques | 1 | 2008 | 1061 | 0.070 |
Why?
| Reproduction | 1 | 2008 | 200 | 0.070 |
Why?
| Cell Communication | 1 | 2008 | 292 | 0.070 |
Why?
| Interferon-gamma | 1 | 2009 | 759 | 0.060 |
Why?
| Cell Line | 1 | 2012 | 2759 | 0.060 |
Why?
| Asthma | 2 | 2016 | 2258 | 0.060 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 618 | 0.060 |
Why?
| Treatment Outcome | 2 | 2012 | 10239 | 0.060 |
Why?
| Interleukin-1 | 1 | 2010 | 972 | 0.060 |
Why?
| Research Design | 1 | 2012 | 1038 | 0.060 |
Why?
| Eosinophils | 1 | 2008 | 324 | 0.060 |
Why?
| Sensitivity and Specificity | 3 | 2018 | 1840 | 0.060 |
Why?
| Reference Values | 2 | 2019 | 791 | 0.060 |
Why?
| Serum Amyloid A Protein | 1 | 2025 | 31 | 0.060 |
Why?
| Neoplasms | 2 | 2016 | 2426 | 0.060 |
Why?
| Acute Disease | 1 | 2008 | 978 | 0.060 |
Why?
| Hemorrhage | 1 | 2009 | 658 | 0.060 |
Why?
| Barrett Esophagus | 3 | 2012 | 149 | 0.060 |
Why?
| Polymorphism, Genetic | 1 | 2008 | 641 | 0.060 |
Why?
| Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| Anti-Inflammatory Agents | 1 | 2008 | 468 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 1701 | 0.060 |
Why?
| Antioxidants | 1 | 2008 | 557 | 0.060 |
Why?
| Antibodies, Protozoan | 1 | 2024 | 31 | 0.060 |
Why?
| Gene Silencing | 1 | 2025 | 180 | 0.060 |
Why?
| Metals, Heavy | 1 | 2024 | 28 | 0.050 |
Why?
| Inflammasomes | 1 | 2025 | 128 | 0.050 |
Why?
| Case-Control Studies | 4 | 2015 | 3334 | 0.050 |
Why?
| Pesticides | 1 | 2024 | 58 | 0.050 |
Why?
| Surveys and Questionnaires | 4 | 2019 | 5355 | 0.050 |
Why?
| Caspase 9 | 1 | 2023 | 54 | 0.050 |
Why?
| STAT3 Transcription Factor | 1 | 2025 | 187 | 0.050 |
Why?
| Exercise | 1 | 2014 | 1923 | 0.050 |
Why?
| Microglia | 1 | 2025 | 227 | 0.050 |
Why?
| Prednisone | 1 | 2024 | 241 | 0.050 |
Why?
| Endothelial Cells | 1 | 2008 | 734 | 0.050 |
Why?
| Immunoglobulin M | 1 | 2024 | 268 | 0.050 |
Why?
| DNA Repair | 1 | 1984 | 208 | 0.050 |
Why?
| Lymphocytes | 1 | 1984 | 369 | 0.050 |
Why?
| Virulence | 1 | 2023 | 253 | 0.050 |
Why?
| Energy Metabolism | 1 | 2008 | 837 | 0.050 |
Why?
| Reactive Oxygen Species | 1 | 2025 | 575 | 0.050 |
Why?
| AMP-Activated Protein Kinases | 1 | 2023 | 187 | 0.050 |
Why?
| Hernia, Hiatal | 2 | 2012 | 31 | 0.050 |
Why?
| Liver Cirrhosis | 1 | 2023 | 274 | 0.050 |
Why?
| Blood Alcohol Content | 1 | 2021 | 5 | 0.050 |
Why?
| Colorado | 2 | 2024 | 4443 | 0.050 |
Why?
| Ventricular Function, Right | 1 | 2023 | 274 | 0.050 |
Why?
| Ventricular Remodeling | 1 | 2023 | 255 | 0.050 |
Why?
| Air Pollution | 1 | 2024 | 225 | 0.040 |
Why?
| United States Department of Veterans Affairs | 1 | 2024 | 637 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2024 | 834 | 0.040 |
Why?
| Firefighters | 1 | 2020 | 39 | 0.040 |
Why?
| Environmental Exposure | 1 | 2024 | 479 | 0.040 |
Why?
| Cathelicidins | 1 | 2018 | 40 | 0.040 |
Why?
| Chronic Disease | 2 | 2015 | 1715 | 0.040 |
Why?
| Patient Care Team | 1 | 2024 | 605 | 0.040 |
Why?
| Patient-Centered Care | 1 | 2024 | 504 | 0.040 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2013 | 528 | 0.040 |
Why?
| Half-Life | 1 | 2018 | 148 | 0.040 |
Why?
| California | 1 | 2019 | 402 | 0.040 |
Why?
| Reference Standards | 1 | 2018 | 168 | 0.040 |
Why?
| Age of Onset | 1 | 2019 | 494 | 0.040 |
Why?
| Disease Progression | 2 | 2015 | 2603 | 0.040 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 102 | 0.030 |
Why?
| Dried Blood Spot Testing | 1 | 2017 | 84 | 0.030 |
Why?
| Forkhead Box Protein O3 | 1 | 2016 | 13 | 0.030 |
Why?
| Shock, Septic | 1 | 2019 | 204 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2017 | 124 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2023 | 1694 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2019 | 473 | 0.030 |
Why?
| Propensity Score | 1 | 2017 | 262 | 0.030 |
Why?
| Bronchoalveolar Lavage | 1 | 2015 | 92 | 0.030 |
Why?
| Rats | 3 | 2014 | 5236 | 0.030 |
Why?
| Histocompatibility Antigens Class II | 1 | 2016 | 359 | 0.030 |
Why?
| Self Report | 1 | 2019 | 796 | 0.030 |
Why?
| Psoriasis | 1 | 2015 | 90 | 0.030 |
Why?
| Endocrine System | 1 | 2014 | 20 | 0.030 |
Why?
| Administration, Topical | 1 | 2015 | 148 | 0.030 |
Why?
| Critical Care | 1 | 2019 | 547 | 0.030 |
Why?
| Hemostasis | 1 | 2014 | 68 | 0.030 |
Why?
| Prevalence | 2 | 2011 | 2540 | 0.030 |
Why?
| Anthropometry | 1 | 2014 | 205 | 0.030 |
Why?
| Canada | 1 | 2015 | 355 | 0.030 |
Why?
| Europe | 1 | 2014 | 366 | 0.030 |
Why?
| Pneumonia, Aspiration | 1 | 2013 | 17 | 0.030 |
Why?
| C-Reactive Protein | 1 | 2016 | 394 | 0.030 |
Why?
| Chemokine CCL5 | 1 | 2013 | 43 | 0.030 |
Why?
| Area Under Curve | 1 | 2014 | 285 | 0.030 |
Why?
| Forecasting | 1 | 2015 | 363 | 0.030 |
Why?
| Virus Diseases | 1 | 2015 | 207 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2024 | 5032 | 0.030 |
Why?
| Metabolomics | 1 | 2017 | 592 | 0.030 |
Why?
| Disease Management | 1 | 2016 | 594 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 760 | 0.030 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2012 | 38 | 0.030 |
Why?
| Acute-Phase Proteins | 1 | 2012 | 67 | 0.020 |
Why?
| Health Surveys | 1 | 2014 | 485 | 0.020 |
Why?
| Gene Expression Regulation | 2 | 2013 | 2520 | 0.020 |
Why?
| Technetium Tc 99m Sulfur Colloid | 1 | 2012 | 6 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2016 | 1435 | 0.020 |
Why?
| Barium Sulfate | 1 | 2012 | 15 | 0.020 |
Why?
| Fluorescence | 1 | 2012 | 159 | 0.020 |
Why?
| Gastric Emptying | 1 | 2012 | 39 | 0.020 |
Why?
| Pregnancy Trimester, First | 1 | 1992 | 133 | 0.020 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 167 | 0.020 |
Why?
| Monitoring, Ambulatory | 1 | 2012 | 84 | 0.020 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1992 | 137 | 0.020 |
Why?
| Esophagitis | 1 | 2011 | 66 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2010 | 46 | 0.020 |
Why?
| bcl-X Protein | 1 | 2010 | 41 | 0.020 |
Why?
| bcl-2-Associated X Protein | 1 | 2010 | 49 | 0.020 |
Why?
| Drug Administration Routes | 1 | 2010 | 39 | 0.020 |
Why?
| Liver Transplantation | 1 | 2018 | 800 | 0.020 |
Why?
| Pneumonia, Viral | 1 | 2015 | 361 | 0.020 |
Why?
| Morbidity | 1 | 2011 | 301 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 465 | 0.020 |
Why?
| Abortion, Induced | 1 | 1992 | 95 | 0.020 |
Why?
| Chromatography, Gel | 1 | 2009 | 124 | 0.020 |
Why?
| Antigens, CD1d | 1 | 2009 | 66 | 0.020 |
Why?
| Reoperation | 1 | 2012 | 555 | 0.020 |
Why?
| Radiography | 1 | 2012 | 863 | 0.020 |
Why?
| Contrast Media | 1 | 2012 | 387 | 0.020 |
Why?
| Esophagus | 1 | 2011 | 253 | 0.020 |
Why?
| Cell Movement | 1 | 2013 | 932 | 0.020 |
Why?
| Nursing Assessment | 1 | 2009 | 54 | 0.020 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1992 | 377 | 0.020 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 985 | 0.020 |
Why?
| Transforming Growth Factor beta1 | 1 | 2009 | 162 | 0.020 |
Why?
| tert-Butyl Alcohol | 1 | 2008 | 1 | 0.020 |
Why?
| Alcohol Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 1991 | 460 | 0.020 |
Why?
| Carrier Proteins | 1 | 2012 | 728 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 760 | 0.020 |
Why?
| Oligopeptides | 1 | 2010 | 256 | 0.020 |
Why?
| Antibodies, Neutralizing | 1 | 2010 | 257 | 0.020 |
Why?
| Collagen | 1 | 2009 | 433 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2008 | 238 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 271 | 0.020 |
Why?
| Body Mass Index | 1 | 2014 | 2244 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2010 | 1091 | 0.020 |
Why?
| Risk-Taking | 1 | 2009 | 344 | 0.020 |
Why?
| Fibroblasts | 1 | 1991 | 946 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 569 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2308 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2013 | 1905 | 0.010 |
Why?
| Pyrazoles | 1 | 2008 | 403 | 0.010 |
Why?
| Testosterone | 1 | 2008 | 382 | 0.010 |
Why?
| Hydroxyurea | 1 | 1984 | 32 | 0.010 |
Why?
| Brain | 1 | 2015 | 2592 | 0.010 |
Why?
| Quality of Life | 1 | 2015 | 2706 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 1984 | 385 | 0.010 |
Why?
| Registries | 1 | 2008 | 1916 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 10457 | 0.010 |
Why?
| Child | 1 | 2014 | 20824 | 0.010 |
Why?
| Bleomycin | 1 | 1991 | 241 | 0.010 |
Why?
| Oxygen | 1 | 1991 | 912 | 0.000 |
Why?
| RNA, Messenger | 1 | 1991 | 2700 | 0.000 |
Why?
|
|
Kovacs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|